Company-reported prevalence
Cytisinicline
Overview
| Field | Value |
|---|---|
| Drug | Cytisinicline |
| Indication | Smoking cessation |
| Disease | Nicotine dependence: adults who smoke combustible cigarettes, adults who use e-cigarettes, and those who want to quit or attempt to quit |
| Company | Achieve Life Sciences (development and commercialization rights in the United States, under an exclusive license and supply agreement with Sopharma AD); Sopharma AD (licensor; markets cytisinicline in Central and Eastern Europe) |
| Documents searched | Achieve Life Sciences website, home page and references page, October 2026; Achieve Life Sciences website, products page, October 2026; Achieve Life Sciences corporate presentation, July 2026; Achieve Life Sciences Form 10-K for 2025, filed March 2026; Achieve Life Sciences Form 10-K/A for 2025, 2026; Achieve Life Sciences press releases of October 7, 2026, October 6, 2026, October 1, 2026, September 28, 2026, August 2026 (second quarter 2026 results), May 19, 2026, 2026 (complete response letter), and September 3, 2025 (NDA acceptance) |
| Data as of | October 14, 2026 |
| Prepared by | AI research agent (Claude); not yet reviewed by a person |
Company statements of prevalence
United States
Number affected: Achieve Life Sciences press release, October 2026
Cited source: 2.1 Agaku 2026
(opens the full-size image in a new tab)Number affected (middle and high school students using e-cigarettes): Achieve Life Sciences press release, October 2026
Cited source: 2.2 Park-Lee 2026
(opens the full-size image in a new tab)Number affected: Achieve Life Sciences website, October 2026
“25M” (opens the source at this quote in a new tab)
“Smokers in the US” (opens the source at this quote in a new tab)
“18M” (opens the source at this quote in a new tab)
“E-Cigs in the US” (opens the source at this quote in a new tab)
Cited source: 2.1 Agaku 2026
(opens the full-size image in a new tab)Prevalence (share of adults who smoke attempting to quit each year): Achieve Life Sciences website, October 2026
Cited source: 2.3 VanFrank 2024
(opens the full-size image in a new tab)Number affected: Achieve Life Sciences corporate presentation, July 2026
“A large, underserved U.S. nicotine-dependence market” (opens the source at this quote in a new tab)
“~48M” (opens the source at this quote in a new tab)
“U.S. tobacco / nicotine users” (opens the source at this quote in a new tab)
“~38M” (opens the source at this quote in a new tab)
“Smokers and/or vapers” (opens the source at this quote in a new tab)
“25M” (opens the source at this quote in a new tab)
“Adult cigarette smokers” (opens the source at this quote in a new tab)
“~18M” (opens the source at this quote in a new tab)
“E-cigarette (vape) users” (opens the source at this quote in a new tab)
Cited source: 2.1 Agaku 2026
(opens the full-size image in a new tab)Number affected (people attempting to quit each year): Achieve Life Sciences corporate presentation, July 2026
“Most try to quit, and most fail” (opens the source at this quote in a new tab)
“~15M” (opens the source at this quote in a new tab)
“Attempt to quit each year” (opens the source at this quote in a new tab)
“~14M” (opens the source at this quote in a new tab)
“Fail to quit each year” (opens the source at this quote in a new tab)
Prevalence (share of adults who smoke wanting to quit): Achieve Life Sciences corporate presentation, July 2026
Prevalence (share of adults who vape planning to quit): Achieve Life Sciences corporate presentation, July 2026
Prevalence (share of adults aged 18 to 34 who vape): Achieve Life Sciences corporate presentation, July 2026
Prevalence (share of adults using e-cigarettes, 2020 and 2024): Achieve Life Sciences corporate presentation, July 2026
Cited source: 2.1 Agaku 2026
(opens the full-size image in a new tab)Number affected: Achieve Life Sciences Form 10-K for 2025, March 2026
Cited source: None stated in the document.
(opens the full-size image in a new tab)Number affected (adults who use e-cigarettes): Achieve Life Sciences Form 10-K for 2025, March 2026
Cited source: None stated in the document.
(opens the full-size image in a new tab)Prevalence (share of adults who smoke wanting to quit or attempting to quit): Achieve Life Sciences Form 10-K for 2025, March 2026
Cited source: None stated in the document.
(opens the full-size image in a new tab)Number affected: Achieve Life Sciences press release, September 2025
Cited source: 2.3 VanFrank 2024; 2.4 Vahratian 2025
(opens the full-size image in a new tab)Number affected (middle and high school students using e-cigarettes): Achieve Life Sciences press release, September 2025
Cited source: 2.5 Jamal 2024
(opens the full-size image in a new tab)Number affected (people attempting to quit each year): Achieve Life Sciences press release, September 2025
Cited source: None stated in the document.
(opens the full-size image in a new tab)Europe
No evidence found.
Global
Number affected (all tobacco users): Achieve Life Sciences Form 10-K for 2025, March 2026
Cited source: None stated in the document.
(opens the full-size image in a new tab)Other countries and regions
No evidence found.
Geography not stated
Prevalence (share of e-cigarette users surveyed by the company intending to quit): Achieve Life Sciences Form 10-K for 2025, March 2026
Cited source: 2.9 Achieve Life Sciences 2021
(opens the full-size image in a new tab)Sources the company cites
Agaku 2026
Reference as the company lists it, press release, October 7, 2026
Reference as the company lists it, corporate presentation, July 2026
Reference as the company lists it, website, references page
Passage carrying the nearest figure
Park-Lee 2026
Reference as the company lists it
Passage carrying the nearest figure
VanFrank 2024
Reference as the company lists it, press release, September 3, 2025
Reference as the company lists it, website, references page
Passage carrying the figure
Vahratian 2025
Reference as the company lists it, press release, September 3, 2025
Reference as the company lists it, corporate presentation, July 2026
Passage carrying the nearest figure
Jamal 2024
Reference as the company lists it
Passage carrying the figure
Centers for disease control and prevention 2026a
Reference as the company lists it
Passage carrying the nearest figure
Centers for disease control and prevention 2026b
National center for health statistics 2026
Reference as the company lists it
Passage carrying the figure
Not quoted: The cited source is an interactive query of the National Health Interview Survey that a person must run; it has no fixed passage to quote.
Achieve life sciences 2021
Passage carrying the figure
Not quoted: The Form 10-K names a company survey presented at the 2021 Society for Research on Nicotine and Tobacco Annual Meeting without a title, authors, or address, and no copy of the presentation was found.
References
- Achieve Life Sciences (2025) press release, September 3, 2025 (opens in a new tab)
- Achieve Life Sciences (2026) corporate presentation, July 2026 (opens in a new tab)
- Achieve Life Sciences (2026) Form 10-K for 2025 (opens in a new tab)
- Achieve Life Sciences (2026) press release, October 7, 2026 (opens in a new tab)
- Achieve Life Sciences (2026) website, home page (opens in a new tab)
- Achieve Life Sciences (2026) website, references page (opens in a new tab)
- Agaku 2026 (opens in a new tab)
- Centers for Disease Control and Prevention (2026) E-Cigarette Use Among Adults (opens in a new tab)
- Centers for Disease Control and Prevention (2026) Smoking Cessation: Fast Facts (opens in a new tab)
- Jamal 2024 (opens in a new tab)
- National Center for Health Statistics (2026) NHIS Adult Summary Health Statistics query tool (opens in a new tab)
- Park-Lee 2026 (opens in a new tab)
- Vahratian 2025 (opens in a new tab)
- VanFrank 2024 (opens in a new tab)























